Shield AI to buy Echodyne for $5.3 billion and raise $2.5 billion

Shield AI agreed on 5 November 2026 to acquire Echodyne in a transaction valued at $5.3 billion. Shield calls Echodyne an industry-leading radar company. The release is datelined San Diego and Kirkland, Washington. An X news cluster on the announcement was updated at about 17:42 UTC, 18:42 CET. [1] [2]

How is the $5.3 billion split?

Of the $5.3 billion, Shield says $4.8 billion will be paid and issued at closing. Up to a further $500 million is contingent on Echodyne meeting agreed performance targets. Shield expects the acquisition to close in early 2027, and it has not closed. Closing depends on regulatory approvals and other customary conditions. [1]

How is Shield raising $2.5 billion?

Shield is raising $2.5 billion, including a $1 billion Series H at a $28.8 billion post-money valuation. The Series H is co-led by Disruptive and Innovation X Capital. Participants include Advent, the Strategic Investment Group of JPMorganChase’s Security and Resiliency Initiative, Snowpoint Ventures, Apandion, Center15 Capital, and others. Shield says Series H proceeds will be used principally to fund the acquisition. [1]

The rest of the $2.5 billion is a $1 billion structured equity investment from funds managed by Blackstone, and $500 million of debt financing led by JPMorgan Chase Bank, N.A. as sole arranger. [1]

What does Shield say Echodyne adds?

Shield says the purchase expands its Mission Systems business into radar and counter-drone work, including software-defined radars for counter-unmanned aircraft systems. Echodyne designs compact solid-state radars with its patented Metamaterials Electronically Scanned Array, or MESA, technology. Shield says those radars are built into hundreds of counter-drone and security systems in more than 40 countries. [1]

Shield says that in September Echodyne received a contract with a $250 million ceiling from Joint Interagency Task Force 401 to supply counter-drone radar to U.S. and allied forces. The release says the radars are integrated onto remote weapon stations, high-energy lasers and high-power microwave systems, and cue interceptors toward incoming drones. Civilian uses named in the release include stadiums, airports, and airspace shared by police and fire services. [1]

Shield says both companies expect triple-digit revenue growth this fiscal year. After closing, Shield says Echodyne will accelerate its existing strategy, the team stays in place, and MESA radars remain available as standalone products. Echodyne chief executive Eben Frankenberg will report to Shield chief executive Gary Steele and stay responsible for Echodyne’s products, manufacturing, and partner and customer engagement. [1]

Echodyne, in Kirkland, Washington, recently opened an 86,350-square-foot factory, a $40 million investment, which Shield says will be able to produce about 30,000 radars a year. In September, Shield named Washington as the production home for X-BAT. Shield’s release also names Hivemind autonomy software, the V-BAT and X-BAT autonomous systems, and Aechelon simulation. Shield was founded in 2015 and says it has offices across the United States, Europe, the Middle East and Asia-Pacific. [1]

What did the two chief executives say?

On the acquisition, J.P. Morgan Securities LLC is exclusive financial advisor to Shield. Wachtell, Lipton, Rosen & Katz is legal advisor to Shield. Covington & Burling LLP advised Shield on regulatory and business diligence. Sullivan & Cromwell LLP is legal advisor to Shield on the financing. Echodyne’s financial advisors are Morgan Stanley & Co. LLC and Robert W. Baird & Co. Incorporated. Fenwick & West LLP is Echodyne’s legal advisor. [1]

Our read

Opinion: The $5.3 billion figure is Shield’s transaction value, not a closed price. $4.8 billion is due at closing and up to $500 million depends on performance targets. The $28.8 billion figure is the stated post-money valuation of the Series H, not an independent appraisal. The release does not say how much of the closing consideration is cash versus stock.

What we could not verify

• An independent valuation of Shield or Echodyne beyond the $5.3 billion transaction value and the $28.8 billion Series H post-money valuation stated by Shield.
• How the $4.8 billion due at closing is split between cash and stock. The release does not say.
• That the acquisition has closed. Shield says it expects to close in early 2027, subject to regulatory approvals and other customary conditions.
• Military performance beyond what the release states. Revenue-growth and capability claims are the companies’ own.